Democrats take aim as Trump abandons drug pricing plan

WASHINGTON (Reuters) – Democrats see U.S. President Donald Trump becoming increasingly vulnerable to criticism about healthcare costs after the administration’s decision to scrap a proposal to lower drug prices, and 2020 White House candidates are rushing to seize the spotlight on the issue.

FILE PHOTO: U.S. President Donald Trump delivers remarks on supporting the passage of the U.S.-Mexico-Canada (USMCA) trade deal during a visit to Derco Aerospace Inc., a Lockheed Martin subsidiary, in Milwaukee, Wisconsin, U.S., July 12, 2019. REUTERS/Carlos Barria?

The debate over the future of the American healthcare system has become a focal point of the Democratic presidential nominating contest. As Trump has failed to make strides to remedy the problem, Democrats are becoming more vocal.

Some Democrats have been making big promises on healthcare, vowing to sweeping overhauls and complete government takeovers.

But even candidates like U.S. Senators Bernie Sanders and Elizabeth Warren, who would abolish private health insurance, are wading into the debate about lowering costs for consumers buying drugs in the current market.

Trump talked regularly about drug prices during his 2016 campaign, but has failed so far to deliver the changes he promised.

On Thursday his administration scrapped one of its most ambitious proposals for lowering prescription medicine prices, backing down from a policy aimed at health insurers and raising the possibility of new measures focused on drugmakers.

The abandoned proposal would have required health insurers to pass billions of dollars in rebates from drugmakers to Medicare patients.

Drug prices directly affect consumers, making it a more pressing concern for voters than debates over the structure of the healthcare system, said Robert Blendon, a political scientist at Harvard University who researches public opinion on healthcare.

Blendon said Trump, having failed to broker any deals in Congress, made his drug price plan too complicated, and voters are unlikely to see him as having made any strides. That is an opportunity for Democrats to offer their own effort at messaging.

A study Blendon produced earlier this year found that given a list of problems, nine out of 10 Americans chose the price of prescription drugs as an extremely important issue.

But voters’ concerns do not extend to the stability or structure of government, with only 25% saying they are concerned about the stability of Medicare.

“Whoever gains anything politically out of this is going to have to talk about this (so that) it sounds like you understand,” Blendon said. “It really is a pocketbook issue.”

On Thursday, U.S. Senators Kirsten Gillibrand unveiled a plan to lower drug prices. On Friday, Democrat Amy Klobuchar announced a plan to help lower the cost of pharmaceuticals purchased by seniors. Warren also has a Medicare pricing plan.

Sanders is heading to Canada later this month for an event to highlight the difference in the price of insulin.

Blendon said it was becoming obvious to candidates like Sanders that they cannot peg their entire healthcare message to arguing for a universal system.

“Medicare for all is not a top issue for older voters,” Blendon said.

FILE PHOTO: Senator Amy Klobuchar speaks at the first U.S. 2020 presidential election Democratic candidates debate in Miami, Florida, U.S., June 26, 2019. REUTERS/Mike Segar

Klobuchar’s proposal, which includes investing in research for a cure for Alzheimer’s disease and improving the stability of Social Security, would allow the government to negotiate Medicare Part D costs, which cover prescriptions for seniors.

Klobuchar, a U.S. senator from Minnesota, would also let people order prescription drugs from countries like Canada, a proposal proponents say would lower costs.

Blendon said import changes are the most popular with voters, who fail to see how drugs from Canada or England are any more risky than ones made in the United States.

Reporting by Ginger Gibson; Editing by Richard Chang

Source

more recommended stories

  • AstraZeneca’s Imfinzi misses main goal of advanced lung cancer study

    FILE PHOTO: A sign is seen.

  • AstraZeneca diabetes drug shows promise in heart failure

    (Reuters) – AstraZeneca (AZN.L) made strides.

  • Study prompts call for lower fluoride consumption by pregnant women

    (Reuters Health) – Adding fluoride to.

  • CDC investigates lung illnesses linked to e-cigarette use

    FILE PHOTO: A man vapes outside.

  • E.coli in water forces Tokyo to cancel swimming at Paratriathlon World Cup

    TOKYO (Reuters) – High levels of.

  • E.coli risk forces Tokyo to cancel swim events at Paratriathlon World Cup

    TOKYO (Reuters) – High levels of.

  • First two Ebola cases confirmed in Congo’s South Kivu – officials

    FILE PHOTO: Children look at a.

  • Surgical training programs not supportive of new parents

    (Reuters Health) – Surgical residents say.

  • Liver disease related to obesity and diabetes rising in U.S.

    (Reuters Health) – The only liver.

  • Ebola ‘no longer incurable’ as Congo trial finds drugs boost survival

    LONDON (Reuters) – Scientists are a.

  • Scientists hail promise of first effective Ebola treatments in Congo trial

    LONDON (Reuters) – Scientists are a.

  • China cuts 2019/20 corn use forecast by 2 million tonnes due to African swine fever

    Corn kernels are seen at a.

  • WHO says no new Ebola cases in Goma, vaccinates over 1,300

    FILE PHOTO: A young woman reacts.

  • Dengue death toll rises in Malaysia, number of cases close to double

    KUALA LUMPUR (Reuters) – Malaysia saw.

  • Amgen wins U.S. patent battle on arthritis drug Enbrel, thwarting Novartis

    (Reuters) – A U.S. judge on.

  • AstraZeneca’s Tagrisso helps lung cancer patients live longer: study

    (Reuters) – AstraZeneca Plc said on.

  • Study shows Apple devices in combo with apps could identify dementia

    FILE PHOTO: The new Apple iPhone.

  • Moving during early pregnancy may increase preterm birth risk

    (Reuters Health) – Moving to a.

  • Drug assistance programs offer little charity to uninsured

    (Reuters Health) – Many patients who.

  • In extreme heat, electric fans inadvisable unless it’s humid

    In extreme heat, electric fans may.

  • Trump administration considers September unveiling of healthcare plan: WSJ

    FILE PHOTO: U.S. President Donald Trump.

  • Bulgaria to compensate owners who cull pigs to help stamp out swine fever

    FILE PHOTO: A pig rests at.

  • Yellow lens glasses don’t improve drivers’ night vision

    (Reuters Health) – – Touted to.

  • U.S. FDA approves Daiichi Sankyo’s treatment for rare joint tumor

    (Reuters) – The U.S. Food and.

  • For some surgeries, hospital rankings not tied to better outcomes

    (Reuters Health) – When it comes.

  • Congo says Rwanda has closed border near Goma

    Congolese customs agents gather at the.

  • Pluristem gets positive results from radiation treatment trials

    TEL AVIV (Reuters) – Israel’s Pluristem Therapeutics.

  • Congress seeks briefing on potential threat to U.S. heparin supply

    WASHINGTON (Reuters) – Leaders of the.

  • U.S. judge blocks Medicaid work requirements in New Hampshire

    (Reuters) – A federal judge on.

  • Bernie Sanders visits Canadian pharmacy, talks drug prices

    WINDSOR, Ontario (Reuters) – U.S. Senator.

  • China detects African swine fever in pigs transported to Liaoning: Xinhua

    BEIJING (Reuters) – China detected African.

  • Sanofi ends partnership with Lexicon to develop diabetes drug

    FILE PHOTO: A logo of Sanofi.